- 专利标题： N-ETHYL-N-PHENYL-1,2-DIHYDRO-4,5-DI-HYDROXY-1-METHYL-2-OXO-3-QUINOLINECARBOXAMIDE, PREPARATION AND USES THEREOF
-
申请号： US15013633申请日： 2016-02-02
-
公开(公告)号： US20160151346A1公开(公告)日： 2016-06-02
- 发明人: Vladimir Ioffe , Konstantin Ulanenko , Avital Laxer , Muhammad Safadi , Danit Licht , Ioana Lovinger , Ulf Tomas Fristedt
- 申请人： Vladimir Ioffe , Konstantin Ulanenko , Avital Laxer , Muhammad Safadi , Danit Licht , Ioana Lovinger , Ulf Tomas Fristedt
- 申请人地址： IL Petach-Tikva
- 专利权人： Teva Pharmaceutical Industries, Ltd.
- 当前专利权人： Teva Pharmaceutical Industries, Ltd.
- 当前专利权人地址： IL Petach-Tikva
- 主分类号： A61K31/4704
- IPC分类号： A61K31/4704 ; B65D50/00 ; B65D41/04 ; A61J1/03 ; B65D1/02
摘要：
The subject invention provides a pharmaceutical composition containing laquinimod or a pharmaceutically acceptable salt thereof, and a compound of N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide or a salt thereof.
信息查询
IPC分类:
